Interview with Murtaza Khorakiwala, Managing Director, Wockhardt
You joined Wockhardt in 2000; you became a member of the board in 2006, and were appointed managing director in 2009. The Indian industry has undergone many changes in the…
GVK BIO, a leading Contract Research & Development Organization – CRDO that services the global Biopharma industry; is headquartered in Hyderabad, India with operations in four sites including California, USA. Established in 2001, GVK BIO has over 16 years of rich experience across the Research and Development value chain with a focus on speed and quality. Our team of over 2000 highly qualified scientists, backed by well-defined and scalable processes, modern facilities and a strong customer-centric partnering approach, focus on bringing our customers’ products to market. We partner with reputed global academic institutions and research laboratories to find efficient, cost-effective and innovative solutions to their Research and Development challenges.
Contact:
Address: GVK Biosciences Private Limited, Plot No. 28 A, IDA Nacharam, Hyderabad –500076, India
Website: http://www.gvkbio.com
Email: corpcomm@gvkbio.com
You joined Wockhardt in 2000; you became a member of the board in 2006, and were appointed managing director in 2009. The Indian industry has undergone many changes in the…
Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully complete Phase III trials, and you are readying to release it…
Since we last met in 2006, the Indian pharmaceutical industry has been doing very well indeed, as a very large number of drugs came off patent. This trend will continue…
Since we last met in 2006, the Indian pharmaceutical industry has been doing very well indeed, as a very large number of drugs came off patent. This trend will continue…
Our last report on India dates back to 2006, right after the Patent Law was passed. What developments have you seen happening in the industry since then? There has been…
“India, as a manufacturing hub, offers safe, effective, quality medicines, at the very best prices. Now, we are on our way to become a R&D hub.” For Dilip Shah, General…
See our Cookie Privacy Policy Here
